Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|April 10, 2016
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trialAmit N Patel, Timothy D Henry, Arshed A Quyyumi, et al.
American Journal of Hypertension|September 20, 2008
Pulse pressure and adverse outcomes in women: a report from the Women's Ischemia Syndrome Evaluation (WISE)R David Anderson, B Clay Sizemore, Genevieve M Barrow, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 8, 2024
Successful Extracorporeal Cardiopulmonary Resuscitation Despite Aortic OcclusionTorben K Becker, John Bruno, Eric I Jeng, et al.
Clinical Cardiology|September 16, 2021
Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarkerChristine Pacheco, Janet Wei, Chrisandra Shufelt, et al.
The American Journal of Cardiology|November 11, 2017
Meta-Analysis of Aspirin Versus Dual Antiplatelet Therapy Following Coronary Artery Bypass GraftingNayan Agarwal, Ahmed N Mahmoud, Nimesh Kirit Patel, et al.
American Heart Journal|July 3, 2002
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteriesR David Anderson, Harvey D White, E Magnus Ohman, et al.
International Journal of Cardiology|July 16, 2026
Left ventricular end-diastolic pressure in women with ischemia and no obstructive coronary artery disease: The women's ischemia syndrome evaluation - Coronary microvascular dysfunction study (WISE-CVD)Sachini Ranasinghe, Benita Tjoe, Joseph Chang, et al.
Lancet (London, England)|June 28, 2002
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trialRobert J Lederman, Farrell O Mendelsohn, R David Anderson, et al.
American Heart Journal|October 11, 2011
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)Daniel F Pauly, B Delia Johnson, R David Anderson, et al.
JACC. Cardiovascular Interventions|December 18, 2017
Trends of Incidence, Clinical Presentation, and In-Hospital Mortality Among Women With Acute Myocardial Infarction With or Without Spontaneous Coronary Artery Dissection: A Population-Based AnalysisAhmed N Mahmoud, Siva Sagar Taduru, Amgad Mentias, et al.
Pageof 10